Propyl Gallate Plays a Nephroprotective Role in Early Stage of Diabetic Nephropathy Associated with Suppression of Glomerular Endothelial Cell Proliferation and Angiogenesis
Figure 2
Immunofluorescent staining of CD31 in nondiabetic rat (a), diabetic rat (b), and diabetic rat treated with propyl gallate (5 mg/Kg body wt). The amount of CD31 positive area was significantly increased in diabetic rats. However, the increase was diminished in diabetic rat treated with propyl gallate.